Arrowhead Research | ARWR - Pre Tax Profit


Arrowhead Research reported $28.27M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Incyte USD 389.94M 92.37M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Merck USD 6.74B 22M Sep/2025
Moderna USD -187M 631M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Novartis USD 4.64B 445M Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Xencor USD -4.27M 1.76M Dec/2025